We found that low-SHCBP1 breast cancer had favorable clinical characteristics, such as more T1 (Figure 1K, 27% vs. 16%) and N0 (Figure 1L, 66.7% vs. 57.1%). This evidence concerns the gene SHCBP1 and breast carcinoma.